See editorial by Fasano on page 181.
The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology
Version of Record online: 17 MAY 2013
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS
European Journal of Neurology
Volume 21, Issue 2, pages 199–205, February 2014
How to Cite
Stepens, A., Groma, V., Skuja, S., Platkājis, A., Aldiņš, P., Ekšteina, I., Mārtiņsone, I., Bricis, R. and Donaghy, M. (2014), The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology. European Journal of Neurology, 21: 199–205. doi: 10.1111/ene.12185
- Issue online: 13 JAN 2014
- Version of Record online: 17 MAY 2013
- Manuscript Accepted: 25 MAR 2013
- Manuscript Received: 6 NOV 2012
Table S1. Patient characteristics stratified by status at follow-up and by index number in a previous observational study.
Table S2. Change in clinical features at follow-up.
Table S3. Change in rating scale measurements, Mn levels and MRI at follow-up.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.